Evidence map›Paper›PMID 21370922›Full record

ArticleBiochemistry2011

Catalytic versus inhibitory promiscuity in cytochrome P450s: implications for evolution of new function.

Robert S Foti, Mathew Honaker, Abhinav Nath, Josh T Pearson, Brian Buttrick, Nina Isoherranen, William M Atkins

Abstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Numerical Methods for Modeling Enzyme Kinetics.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.The Journal of steroid biochemistry and molecular biology · 2015
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert S FotiDepartment of Drug Metabolism and Pharmacokinetics, Amgen Inc., Seattle, Washington 98119, United States.
Mathew Honaker
Abhinav Nath
Josh T Pearson
Brian Buttrick
Nina Isoherranen
William M Atkins

Funding

TOXIC DRUG INTERACTIONS WITH VALPROIC ACIDP01GM032165 · NIGMS · UNIVERSITY OF WASHINGTON · PI RETTIE, ALLAN EDWARD · 1985 to 2012
$18.3M
Glutathione S-Transferases and Oxidative StressR01GM062284 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 2002 to 2011
$2.0M
NIGMS NIH HHS GM32165NIGMS NIH HHS R01 GM062284
6 · The paper itself

Abstract

Catalytically promiscuous enzymes are intermediates in the evolution of new function from an existing pool of protein scaffolds. However, promiscuity will only confer an evolutionary advantage if other useful properties are not compromised or if there is no "negative trade-off" induced by the mutations that yield promiscuity. Therefore, identification and characterization of negative trade-offs incurred during the emergence of promiscuity are required to further develop the evolutionary models and to optimize in vitro evolution. One potential negative trade-off of catalytic promiscuity is increased susceptibility to inhibition, or inhibitory promiscuity. Here we exploit cytochrome P450s (CYPs) as a model protein scaffold that spans a vast range of catalytic promiscuity and apply a quantitative index to determine the relationship between promiscuity of catalysis and promiscuity of inhibition for a series of homologues. The aim of these studies is to begin to identify properties that, in general, correlate with catalytic promiscuity, hypothetically such as inhibitory promiscuity. Interestingly, the data indicate that the potential negative trade-off of inhibitory promiscuity is nearly insignificant because even highly substrate specific CYPs have high inhibitory promiscuity, with little incremental increase in susceptibility to inhibitory interactions as the substrate promiscuity increases across the series of enzymes. In the context of evolution, inhibitory promiscuity is not an obligate negative trade-off for catalytic promiscuity.

Indexed as

Cytochrome P-450 Enzyme InhibitorsEvolution, MolecularModels, BiologicalBiocatalysisChemical PhenomenaCytochrome P-450 Enzyme SystemDrug InteractionsHumansLiverMicrosomesModels, MolecularRecombinant ProteinsStatistics as TopicSubstrate SpecificityCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemRecombinant Proteins

Identifiers

PMID21370922
PMCPMC3068220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.